Monarch Partners Asset Management LLC Iveric Bio, Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Iveric Bio, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 186,706 shares of ISEE stock, worth $0. This represents 1.22% of its overall portfolio holdings.
Number of Shares
186,706
Previous 139,315
34.02%
Holding current value
$0
Previous $2.5 Million
59.94%
% of portfolio
1.22%
Previous 0.75%
Shares
8 transactions
Others Institutions Holding ISEE
# of Institutions
7Shares Held
250KCall Options Held
40KPut Options Held
0-
Pictet Asset Management Sa Geneva 73, V825KShares$00.0% of portfolio
-
Jefferies Group LLC New York, NY19.5KShares$00.0% of portfolio
-
Aevitas Wealth Management, Inc.17.8KShares$00.22% of portfolio
-
Endurance Wealth Management, Inc.1.5KShares$00.01% of portfolio
-
Wipfli Financial Advisors Llc,39Shares$00.0% of portfolio
About IVERIC bio, Inc.
- Ticker ISEE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,078,000
- Description
- IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...